COOPER COMPANIES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COOPER COMPANIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Oct 31, 2018 | $651.50M | Dec 21, 2018 |
| FY2018 | Jul 31, 2018 | $660.00M | Dec 21, 2018 |
| FY2018 | Apr 30, 2018 | $631.30M | Dec 21, 2018 |
| FY2018 | Jan 31, 2018 | $590.00M | Dec 21, 2018 |
| FY2018 | Oct 31, 2017 | $561.50M | Dec 21, 2018 |
| FY2018 | Jul 31, 2017 | $556.00M | Dec 21, 2018 |
| FY2018 | Apr 30, 2017 | $522.40M | Dec 21, 2018 |
| FY2018 | Jan 31, 2017 | $499.10M | Dec 21, 2018 |
| FY2018 | Oct 31, 2016 | $1.97B | Dec 21, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.09B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $3.90B | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $3.59B | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $3.31B | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $2.92B | Dec 8, 2023 |
| FY2020 | Oct 31, 2020 | $681.60M | Dec 11, 2020 |
| FY2020 | Jul 31, 2020 | $578.20M | Dec 11, 2020 |
| FY2020 | Apr 30, 2020 | $524.90M | Dec 11, 2020 |
| FY2020 | Jan 31, 2020 | $646.20M | Dec 11, 2020 |
| FY2020 | Oct 31, 2019 | $691.60M | Dec 11, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $561.50M | Dec 22, 2017 |
| FY2017 | Jul 31, 2017 | $556.00M | Dec 22, 2017 |
| FY2017 | Apr 30, 2017 | $522.40M | Dec 22, 2017 |
| FY2017 | Jan 31, 2017 | $499.10M | Dec 22, 2017 |
| FY2017 | Oct 31, 2016 | $518.70M | Dec 22, 2017 |
| FY2017 | Jul 31, 2016 | $514.70M | Dec 22, 2017 |
| FY2017 | Apr 30, 2016 | $483.80M | Dec 22, 2017 |
| FY2017 | Jan 31, 2016 | $449.60M | Dec 22, 2017 |
| FY2016 | Oct 31, 2015 | $455.50M | Dec 22, 2016 |
| FY2016 | Jul 31, 2015 | $461.70M | Dec 22, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $2.68B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $2.60B | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $2.36B | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $2.14B | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $1.96B | Dec 8, 2023 |
| FY2020 | Oct 31, 2020 | $424.00M | Dec 11, 2020 |
| FY2020 | Jul 31, 2020 | $360.80M | Dec 11, 2020 |
| FY2020 | Apr 30, 2020 | $323.50M | Dec 11, 2020 |
| FY2020 | Jan 31, 2020 | $426.50M | Dec 11, 2020 |
| FY2020 | Oct 31, 2019 | $455.00M | Dec 11, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $374.90M | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $392.30M | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $294.20M | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $385.80M | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $2.94B | Dec 8, 2023 |
| FY2020 | Oct 31, 2020 | $81.20M | Dec 11, 2020 |
| FY2020 | Jul 31, 2020 | $55.20M | Dec 11, 2020 |
| FY2020 | Apr 30, 2020 | $11.50M | Dec 11, 2020 |
| FY2020 | Jan 31, 2020 | $90.50M | Dec 11, 2020 |
| FY2020 | Oct 31, 2019 | $121.00M | Dec 11, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $682.90M | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $705.70M | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $533.10M | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $507.60M | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $505.80M | Dec 8, 2023 |
| FY2022 | Oct 31, 2020 | $311.80M | Dec 9, 2022 |
| FY2021 | Oct 31, 2019 | $546.70M | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $403.10M | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $429.10M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $324.10M | Dec 21, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $172.20M | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $155.10M | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $137.40M | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $110.30M | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $92.70M | Dec 8, 2023 |
| FY2022 | Oct 31, 2020 | $93.30M | Dec 9, 2022 |
| FY2021 | Oct 31, 2019 | $86.70M | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $84.80M | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $69.20M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $65.40M | Dec 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.63B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $1.53B | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $1.50B | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $1.34B | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $1.21B | Dec 8, 2023 |
| FY2022 | Oct 31, 2020 | $992.50M | Dec 9, 2022 |
| FY2021 | Oct 31, 2019 | $996.20M | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $973.30M | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $799.10M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $722.80M | Dec 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $796.10M | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $709.30M | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $607.50M | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $692.40M | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $738.60M | Dec 8, 2023 |
| FY2022 | Oct 31, 2020 | $486.60M | Dec 9, 2022 |
| FY2021 | Oct 31, 2019 | $713.20M | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $668.90M | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $593.60M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $509.60M | Dec 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $362.40M | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $421.20M | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $392.50M | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $242.00M | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $214.40M | Dec 8, 2023 |
| FY2022 | Oct 31, 2020 | $310.40M | Dec 9, 2022 |
| FY2021 | Oct 31, 2019 | $292.10M | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $193.60M | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $127.20M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $152.60M | Dec 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $12.39B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $12.32B | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $11.66B | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $11.49B | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $9.61B | Dec 8, 2023 |
| FY2022 | Oct 31, 2020 | $6.74B | Dec 9, 2022 |
| FY2021 | Oct 31, 2019 | $6.27B | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $6.11B | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $4.86B | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $4.48B | Dec 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.16B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $4.23B | Dec 5, 2025 |
| FY2024 | Oct 31, 2023 | $4.11B | Dec 6, 2024 |
| FY2023 | Oct 31, 2022 | $4.32B | Dec 8, 2023 |
| FY2022 | Oct 31, 2021 | $2.66B | Dec 9, 2022 |
| FY2021 | Oct 31, 2020 | $2.91B | Dec 10, 2021 |
| FY2020 | Oct 31, 2019 | $2.65B | Dec 11, 2020 |
| FY2019 | Oct 31, 2018 | $2.81B | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $1.68B | Dec 21, 2018 |
| FY2017 | Oct 31, 2016 | $1.78B | Dec 22, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $8.24B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $8.08B | Dec 5, 2025 |
| FY2024 | Oct 31, 2023 | $7.55B | Dec 6, 2024 |
| FY2023 | Oct 31, 2022 | $7.17B | Dec 8, 2023 |
| FY2022 | Oct 31, 2021 | $6.94B | Dec 9, 2022 |
| FY2021 | Oct 31, 2020 | $3.82B | Dec 10, 2021 |
| FY2020 | Oct 31, 2019 | $3.63B | Dec 11, 2020 |
| FY2019 | Oct 31, 2018 | $3.31B | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $3.18B | Dec 21, 2018 |
| FY2017 | Oct 31, 2016 | $2.70B | Dec 22, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.85B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $3.84B | Dec 5, 2025 |
| FY2024 | Oct 31, 2023 | $3.62B | Dec 6, 2024 |
| FY2023 | Oct 31, 2022 | $3.61B | Dec 8, 2023 |
| FY2022 | Oct 31, 2021 | $2.57B | Dec 9, 2022 |
| FY2021 | Oct 31, 2020 | $2.45B | Dec 10, 2021 |
| FY2021 | Oct 31, 2019 | $2.43B | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $2.39B | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $2.35B | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $2.16B | Dec 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $7.64B | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $7.27B | Dec 5, 2025 |
| FY2024 | Oct 31, 2023 | $6.88B | Dec 6, 2024 |
| FY2023 | Oct 31, 2022 | $6.58B | Dec 8, 2023 |
| FY2022 | Oct 31, 2021 | $6.20B | Dec 9, 2022 |
| FY2021 | Oct 31, 2020 | $3.26B | Dec 10, 2021 |
| FY2020 | Oct 31, 2019 | $3.03B | Dec 11, 2020 |
| FY2019 | Oct 31, 2018 | $2.58B | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $2.43B | Dec 21, 2018 |
| FY2017 | Oct 31, 2016 | $2.05B | Dec 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $110.60M | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $107.60M | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $120.80M | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $138.20M | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $95.90M | Dec 8, 2023 |
| FY2022 | Oct 31, 2020 | $115.90M | Dec 9, 2022 |
| FY2021 | Oct 31, 2019 | $89.00M | Dec 10, 2021 |
| FY2020 | Oct 31, 2018 | $77.70M | Dec 11, 2020 |
| FY2019 | Oct 31, 2017 | $88.80M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $100.80M | Dec 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 1 | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | 1 | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | 1 | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | 1 | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | 59 | Dec 8, 2023 |
| FY2020 | Oct 31, 2020 | 1 | Dec 11, 2020 |
| FY2020 | Jul 31, 2020 | 1 | Dec 11, 2020 |
| FY2020 | Apr 30, 2020 | 0 | Dec 11, 2020 |
| FY2020 | Jan 31, 2020 | 1 | Dec 11, 2020 |
| FY2020 | Oct 31, 2019 | 2 | Dec 11, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 1 | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | 1 | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | 1 | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | 1 | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | 59 | Dec 8, 2023 |
| FY2020 | Oct 31, 2020 | 1 | Dec 11, 2020 |
| FY2020 | Jul 31, 2020 | 1 | Dec 11, 2020 |
| FY2020 | Apr 30, 2020 | 0 | Dec 11, 2020 |
| FY2020 | Jan 31, 2020 | 1 | Dec 11, 2020 |
| FY2020 | Oct 31, 2019 | 2 | Dec 11, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 195.90M | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | 199.60M | Dec 5, 2025 |
| FY2024 | Oct 31, 2023 | 198.10M | Dec 6, 2024 |
| FY2023 | Oct 31, 2022 | 49.30M | Dec 8, 2023 |
| FY2022 | Oct 31, 2021 | 49.30M | Dec 9, 2022 |
| FY2021 | Oct 31, 2020 | 49.10M | Dec 10, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $0 | Dec 5, 2025 |
| FY2025 | Oct 31, 2024 | $0 | Dec 5, 2025 |
| FY2025 | Oct 31, 2023 | $3.00M | Dec 5, 2025 |
| FY2024 | Oct 31, 2022 | $3.00M | Dec 6, 2024 |
| FY2023 | Oct 31, 2021 | $3.00M | Dec 8, 2023 |
| FY2021 | Aug 11, 2021 | $1.50M | Dec 10, 2021 |
| FY2021 | Feb 9, 2021 | $1.50M | Dec 10, 2021 |
| FY2022 | Oct 31, 2020 | $3.00M | Dec 9, 2022 |
| FY2021 | Aug 7, 2020 | $1.50M | Dec 10, 2021 |
| FY2021 | Feb 10, 2020 | $1.50M | Dec 10, 2021 |